M.D.C. Stock Price, News & Analysis (NYSE:MDC)

M.D.C. trades on the New York Stock Exchange (NYSE) under the ticker symbol "MDC."

M.D.C. declared a quarterly dividend on Monday, July 22nd. Shareholders of record on Wednesday, August 7th will be paid a dividend of $0.30 per share on Wednesday, August 21st. This represents a $1.20 dividend on an annualized basis and a yield of 2.83%. The ex-dividend date is Tuesday, August 6th. View M.D.C.'s Dividend History.

M.D.C. Holdings, Inc. (NYSE:MDC) announced its quarterly earnings results on Wednesday, July, 31st. The construction company reported $0.86 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.78 by $0.08. The construction company had revenue of $732.84 million for the quarter, compared to analysts' expectations of $727.20 million. M.D.C. had a return on equity of 13.24% and a net margin of 6.64%. The firm's revenue was down 2.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.03 EPS. View M.D.C.'s Earnings History.

M.D.C. is scheduled to release their next quarterly earnings announcement on Thursday, November 7th 2019. View Earnings Estimates for M.D.C..

5 brokerages have issued 12-month target prices for M.D.C.'s stock. Their predictions range from $31.00 to $49.00. On average, they expect M.D.C.'s share price to reach $38.75 in the next twelve months. This suggests that the stock has a possible downside of 8.7%. View Analyst Price Targets for M.D.C..

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for M.D.C. in the last year. There are currently 2 hold ratings, 2 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for M.D.C..

News articles about MDC stock have trended somewhat negative recently, according to InfoTrie. The research firm identifies positive and negative press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. M.D.C. earned a media sentiment score of -1.3 on InfoTrie's scale. They also assigned headlines about the construction company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View News Stories for M.D.C..

M.D.C. saw a increase in short interest in the month of August. As of August 15th, there was short interest totalling 2,036,500 shares, an increase of 35.0% from the July 15th total of 1,508,300 shares. Based on an average daily trading volume, of 437,000 shares, the short-interest ratio is currently 4.7 days. Currently, 4.2% of the company's stock are sold short. View M.D.C.'s Current Options Chain.

Some companies that are related to M.D.C. include PulteGroup (PHM), Toll Brothers (TOL), KB Home (KBH), Meritage Homes (MTH), Taylor Morrison Home (TMHC), TRI Pointe Group (TPH), LGI Homes (LGIH), M/I Homes (MHO), Century Communities (CCS), William Lyon Homes (WLH), Green Brick Partners (GRBK), Beazer Homes USA (BZH), Hovnanian Enterprises (HOV), New Home (NWHM) and Comstock Holding Companies (CHCI).

Based on aggregate information from My MarketBeat watchlists, some companies that other M.D.C. investors own include Bank of Hawaii (BOH), InterDigital Wireless (IDCC), Stag Industrial (STAG), Procter & Gamble (PG), Celgene (CELG), Ford Motor (F), Cisco Systems (CSCO), Intel (INTC), Exxon Mobil (XOM) and Gilead Sciences (GILD).

M.D.C.'s stock is owned by a number of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (14.36%), BlackRock Inc. (14.35%), Vanguard Group Inc. (8.59%), LSV Asset Management (3.67%), Hamlin Capital Management LLC (3.00%) and Bank of New York Mellon Corp (2.72%). Company insiders that own M.D.C. stock include David D Mandarich, David E Blackford, David Siegel, Herbert T Buchwald, Larry A Mizel, Michael A Berman, Michael Touff, Paris G Reece III, Raymond T Baker and Robert Nathaniel Martin. View Institutional Ownership Trends for M.D.C..

MDC stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Allianz Asset Management GmbH, Morgan Stanley, BNP Paribas Arbitrage SA, Balyasny Asset Management LLC, Vertex One Asset Management Inc., LSV Asset Management and Heartland Advisors Inc.. Company insiders that have sold M.D.C. company stock in the last year include David D Mandarich, David E Blackford, David Siegel, Herbert T Buchwald, Larry A Mizel, Michael A Berman, Michael Touff, Paris G Reece III, Raymond T Baker and Robert Nathaniel Martin. View Insider Buying and Selling for M.D.C..

MDC stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., BlackRock Inc., JPMorgan Chase & Co., Nuveen Asset Management LLC, Bank of New York Mellon Corp, Intrinsic Edge Capital Management LLC, Northern Trust Corp and First Trust Advisors LP. View Insider Buying and Selling for M.D.C..

Shares of MDC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of MDC stock can currently be purchased for approximately $42.43.

M.D.C. has a market capitalization of $2.63 billion and generates $2.98 billion in revenue each year. The construction company earns $210.78 million in net income (profit) each year or $3.67 on an earnings per share basis. M.D.C. employs 1,581 workers across the globe.View Additional Information About M.D.C..

The official website for M.D.C. is http://www.mdcholdings.com/.

M.D.C.'s mailing address is 4350 S MONACO STREET SUITE 500, DENVER CO, 80237. The construction company can be reached via phone at 303-773-1100 or via email at [email protected]